Korro Bio (KRRO) Change in Cash (2018 - 2026)
Korro Bio's (KRRO) quarterly Change in Cash came in at $39.9 million in Q1 2026, up 369.04% YoY from $8.5 million in Q1 2025, and up 1810.55% on a QoQ basis from -$2.3 million in Q4 2025.
Korro Bio (KRRO) Change in Cash (2018 - 2026) Analysis & Trends
Korro Bio (KRRO) has 9 years of Change in Cash data on file, last reported at $39.9 million in Q1 2026.
- Quarterly Change in Cash rose 369.04% year-over-year to $39.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (up 96.87% YoY) and the FY2025 annual result came in at -$33.8 million, up 70.35% from the prior year.
- Change in Cash improved to $39.9 million in Q1 2026, from -$2.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $121.8 million in Q4 2023 to a low of -$49.4 million in Q2 2024.
- A 5-year average of -$1.1 million and a median of -$9.3 million in 2024 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 1897.37% in 2023, down 996.81% in 2023.
- Tracing KRRO's Change in Cash over 5 years: stood at -$6.8 million in 2022, then jumped by 1897.37% to $121.8 million in 2023, then plunged by 107.66% to -$9.3 million in 2024, then jumped by 75.02% to -$2.3 million in 2025, then jumped by 1810.55% to $39.9 million in 2026.
- The last three Change in Cash figures came in at $39.9 million (Q1 2026), -$2.3 million (Q4 2025), and -$9.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Korro Bio | 231.77 Mn | 116.73 Mn | - | -37.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -37.79 Mn |
| Mar 31, 2026 | 39.87 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Sep 30, 2025 | -9.46 Mn |
| Jun 30, 2025 | -30.53 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | -9.33 Mn |
| Sep 30, 2024 | -27.95 Mn |
| Jun 30, 2024 | -49.43 Mn |
| Mar 31, 2024 | -27.36 Mn |
| Dec 31, 2023 | 121.83 Mn |
| Sep 30, 2023 | -13.21 Mn |
| Jun 30, 2023 | -18.17 Mn |
| Mar 31, 2023 | 41.20 Mn |
| Dec 31, 2022 | -6.78 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | -7.46 Mn |
| Mar 31, 2022 | -29.81 Mn |
| Dec 31, 2021 | -32.43 Mn |
| Sep 30, 2021 | -23.09 Mn |